Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LIPG | Q9Y5X9 | 11/20 | 0.46 |
| ▸ | LPL | P06858 | 10/20 | 0.46 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.39 |
| ▸ | CA1 | P00915 | 1/20 | 0.34 |
| ▸ | CA2 | P00918 | 1/20 | 0.34 |
| ▸ | CA9 | Q16790 | 1/20 | 0.34 |
| ▸ | SNCA | P37840 | 1/20 | 0.34 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.34 |
| ▸ | F11 | P03951 | 1/20 | 0.33 |
| ▸ | CTSD | P07339 | 1/20 | 0.33 |
| ▸ | BACE1 | P56817 | 1/20 | 0.33 |
| ▸ | CDC7 | O00311 | 1/20 | 0.33 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.33 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.33 |
| ▸ | PRKACA | P17612 | 1/20 | 0.33 |
| ▸ | CDK2 | P24941 | 1/20 | 0.33 |
| ▸ | GSK3B | P49841 | 1/20 | 0.33 |
| ▸ | CLK4 | Q9HAZ1 | 1/20 | 0.33 |
| ▸ | IRAK4 | Q9NWZ3 | 1/20 | 0.33 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12781865 | 0.90 | LIPG (0.56) | LIPGLPLCA1CA2CA9 | |
| SCHEMBL1753517 | 0.90 | LIPG (0.50) | LIPGLPLCA1CA2CA9 | |
| SCHEMBL70387 | 0.87 | LIPG (0.59) | LIPGLPLCA1CA2CA9 | |
| SCHEMBL429991 | 0.86 | LIPG (0.64) | LIPGLPLPDK2CA1CA2 | |
| SCHEMBL19716153 | 0.86 | LIPG (0.46) | LIPGLPLPDK2CTSDBACE1 | |
| SCHEMBL22222575 | 0.85 | LIPG (0.49) | LIPGLPLPDK2DGAT1BACE1 | |
| SCHEMBL22222520 | 0.85 | LIPG (0.49) | LIPGLPLPDK2DGAT1BACE1 | |
| SCHEMBL69358 | 0.84 | LIPG (0.47) | LIPGLPLCA1CA2CA9 | |
| SCHEMBL431646 | 0.83 | LIPG (0.51) | LIPGLPLPDK2CA1CA2 | |
| SCHEMBL430244 | 0.83 | LIPG (0.51) | LIPGLPLPDK2CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107400139-B | Heterocyclic compound and organic light-emitting device including the same | 三星显示有限公司 | 2021-09-28 | — | — | CN | disclosed |
| US-10305046-B2 | Heterocyclic compound and organic light-emitting device including the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2019-05-28 | — | — | US | disclosed |
| US-20170338419-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2017-11-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10305046-B2 | Heterocyclic compound and organic light-emitting device including the same | CYP1A1, CRY1, CCNA1 | LIPG 4202/4885LPL 3653/4885PDK2 1820/4885 |
| US-20170338419-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | CYP1A1, CRY1, CCNA1 | LIPG 4202/4885LPL 3653/4885PDK2 1820/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.